Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus ointment for prevention of breast cancer-related lymphedema
NCT04390685Phase 2Unknown
- Sponsor
- University Hospital Odense
- Start
- Feb 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tacrolimus Ointment 0.1% Iwaki in lymphedema, sponsored by University Hospital Odense. Status: unknown.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT04390685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390685.